Eisai Co Stock Fundamentals

EII Stock  EUR 30.05  1.24  4.30%   
Eisai Co fundamentals help investors to digest information that contributes to Eisai Co's financial success or failures. It also enables traders to predict the movement of Eisai Stock. The fundamental analysis module provides a way to measure Eisai Co's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eisai Co stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Eisai Co Company Operating Margin Analysis

Eisai Co's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Eisai Co Operating Margin

    
  (0.02) %  
Most of Eisai Co's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eisai Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Eisai Co has an Operating Margin of -0.0248%. This is 99.93% lower than that of the Healthcare sector and 99.93% lower than that of the Drug Manufacturers - Specialty & Generic industry. The operating margin for all Germany stocks is 99.55% lower than that of the firm.

Eisai Co Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eisai Co's current stock value. Our valuation model uses many indicators to compare Eisai Co value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eisai Co competition to find correlations between indicators driving Eisai Co's intrinsic value. More Info.
Eisai Co is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eisai Co's earnings, one of the primary drivers of an investment's value.

Eisai Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eisai Co's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eisai Co could also be used in its relative valuation, which is a method of valuing Eisai Co by comparing valuation metrics of similar companies.
Eisai is rated # 5 in operating margin category among its peers.

Eisai Fundamentals

About Eisai Co Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Eisai Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eisai Co using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eisai Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. Eisai Co., Ltd. was founded in 1941 and is headquartered in Tokyo, Japan. EISAI LTD operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10683 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Eisai Stock

Eisai Co financial ratios help investors to determine whether Eisai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eisai with respect to the benefits of owning Eisai Co security.